ABIGAIL CICERO: Open Payments
NPI 1649813700 · MENTOR, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 45 payments from 16 companies in 2025. Trend: 2023 $757 · 2024 $1,001 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $137 |
| PFIZER INC. | 6 | $120 |
| ABBVIE INC. | 5 | $108 |
| Exact Sciences Corporation | 4 | $85 |
| Lilly USA, LLC | 5 | $83 |
| Novo Nordisk Inc | 4 | $63 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 7 | $42 |
| Corcept Therapeutics | 2 | $39 |
Products named: General - Pain Management, ELIQUIS, Cologuard Collection Kit, MOUNJARO, QULIPTA, Veozah, VOQUEZNA, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
